CHEPLAPHARM Arzneimittel GmbH
support_agent

Your contact persons

Press and News Items

Welcome to our news section. This is where we provide you with first hand news and information from and about CHEPLAPHARM. We offer you a broad range of current information and materials for all publishing needs. All texts and images are free to use for editorial purposes.

News-Categories

All News

Investors Domain Investor Relations Press releases

01/05/2021

CHEPLAPHARM completes it´s largest acquisition so far

more chevron_right
Investors Domain Investor Relations Press releases

01/04/2021

CHEPLAPHARM acquires rights to Atacand® in more than 70 markets

more chevron_right
Investor Relations

04/06/2020

CHEPLAPHARM - Quarterly Update Call Q4 / FY 2019

Cheplapharm Arzneimittel GmbH - Quarterly Update Call Q4 / FY 2019 | Wednesday, 08 April 2020, 10:30 BST | 11:30 CEST


more chevron_right
Investor Relations

03/30/2020

Corona Virus (COVID-19) Impact on CHEPLAPHARM activities

Due to the COVID-19 situation, CHEPLAPHARM Arzneimittel GmbH is closely monitoring the potential impact on the various Supply Chains and is committed to keep a transparent approach to all involved …


more chevron_right
Back to top expand_less